Junious Media NetworkMonday, November 16, 2026
Juni/Tech
Advertisement
AI

Apple Launches Health AI Study to Examine Conversational Tools

Apple launched a research study and app to understand how people use conversational AI health tools and whether the responses are actually useful.

Key points

  1. Apple launched the Apple Health AI Usage Study in the United States, seeking up to 200,000 participants to examine how people interact with conversational AI health tools.
  2. The study was built in collaboration with OpenEvidence, a clinical AI platform that grounds responses in peer-reviewed research from publications such as The New England Journal of Medicine.
  3. Participants must be at least 21 years old, based in the U.S., and use an iPhone 15 Pro or later running iOS 26 or later.
  4. Study data will be anonymized and will not be used to train AI models, and OpenEvidence deletes query and response data within 24 hours.

Apple announced a new research project to study how people use conversational AI tools for health questions. The company launched the Apple Health AI Usage Study in the United States, opening enrollment through a dedicated iPhone app. The study will examine user trust, response quality, comprehension, and whether AI-driven health information leads people to act on what they learn.

The announcement comes as major AI companies have moved into health-related features. Apple's approach is rooted in formal research: the company wants to understand how clinically grounded AI answers perform before making decisions about future tools, Apple said.

What Apple Wants to Learn

The study focuses on a central question that has followed consumer health AI since it emerged: do these tools actually help people? Apple said it wants to measure how well participants understand what the app tells them, how much they trust the responses, and whether the information changes any of their everyday health decisions.

The app lets participants ask health questions in plain language and receive responses written to be accessible rather than clinical. Each reply includes links to peer-reviewed sources so participants can check the evidence themselves. After reading a response, participants rate it on criteria including accuracy, detail, and relevance, according to the Verge.

The study app will also explore how AI tools can help participants prepare for visits with their own doctors, Apple said. That positions the tool as a bridge between consumer health information and clinical care, rather than a replacement for professional advice. Apple designed the app to present complex medical concepts in accessible language, recognizing that health literacy varies widely among adults.

Advertisement

Monthly surveys round out the data collection. The app also includes safety guardrails designed to detect certain concerning questions and direct participants toward a provider or other resource when needed.

Apple's Clinical Partner and Medical Sources

Apple built the study in collaboration with OpenEvidence, a clinical AI platform used widely by healthcare professionals. OpenEvidence generates responses by drawing on peer-reviewed research from publications including The New England Journal of Medicine, the Journal of the American Medical Association, and Nature, Apple said. The partnership brings together OpenEvidence's medically grounded AI and a research experience designed by Apple.

Advertisement

Sumbul Desai, M.D., Apple's vice president of Health and Fitness, said the company believes "responsible innovation starts with scientific rigor and clinical grounding." Desai said the study is meant to advance the broader scientific conversation about how AI health tools should be designed and evaluated.

Robert M. Wachter, M.D., professor and chair of the Department of Medicine at the University of California San Francisco, said patients and clinicians are both turning to AI but that the tools they rely on are being developed and tested in separate environments. When both groups draw on the same trustworthy sources, Wachter said, clinical conversations improve and patients arrive better prepared for their appointments.

One concern the study addresses is that AI tools built on large language models can sometimes produce incomplete or unclear answers. Apple's newsroom noted that research is critical because of that risk, and that the goal is to present health information with greater clarity.

Eligibility for the Apple Health AI Usage Study

Enrollment is open to U.S. residents who are at least 21 years old, Apple said. Participants must have an iPhone 15 Pro or later running iOS 26 or later, with Apple Intelligence enabled on the device. Apple is seeking up to 200,000 participants, and TechCrunch reported the study is designed to run for more than 12 months.

Advertisement

Although Apple Intelligence must be active on the device, the app does not use Apple Intelligence itself. The Verge noted that the study app relies on text-based prompts and is not connected to Siri. Users can dictate questions through the standard iOS keyboard as an alternative to typing.

During enrollment, participants are given the option to share health data from Apple's HealthKit. Available data types include resting heart rate, physical activity, sleep records, and clinical lab results. Sharing that data is voluntary and is intended to let the app generate more personally relevant responses.

The app is available for download in the United States, with enrollment open as of the announcement. Participants can join at any point during the enrollment period.

Privacy and Data Protections

Apple said privacy was built into the study design from the start. Data is anonymized before it is sent to a secure third-party cloud provider, and nothing collected in the study will be used to train any AI model. TechCrunch reported that OpenEvidence deletes all query and response data within 24 hours.

Advertisement

Participants decide which HealthKit data types to share and can withhold any survey responses at any time. Apple has put security measures in place to protect participant confidentiality and the integrity of research data throughout the study.

The study app carries a standard medical disclaimer: it is not built to diagnose or treat any condition, and it does not substitute for the advice of a doctor or clinician. Apple urges participants to consult a medical professional to address health concerns or verify medical information.

Advertisement

Broader Context and What to Watch

The health AI space has grown rapidly. TechCrunch reported that OpenAI said earlier this year that users submit more than 300 million health-related queries each week. That figure reflects broad public demand for AI-assisted health information, even as questions remain about how accurate and useful those answers actually are.

Apple's decision to study the question formally sets it apart from companies that released health AI products and adjusted them based on user feedback after the fact. The study draws a line between consumer health AI tools and clinical systems, with the aim of finding whether that divide can be bridged in a responsible and evidence-based way.

The study design includes a feature that separates it from typical consumer AI health apps: responses are anchored to specific peer-reviewed papers, and participants see those citations directly. That approach addresses a persistent criticism of consumer health AI - that it produces plausible-sounding answers without linking them to verifiable clinical evidence.

Apple's newsroom said the aim is to inform responsible design across the industry, not just within Apple. Whether findings eventually shape features in the iOS Health app or in how Siri handles health questions has not been confirmed by the company. Results from more than a year of data will be watched closely by researchers and health technology developers.

For everyday users, the study represents an early signal of where Apple may be heading with health AI. The company has been cautious about deploying AI in medical contexts, and the research-first stance suggests it intends to continue that careful approach as it weighs future product decisions.

Advertisement

Sources